GH

Guardant Health Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 0/10
Guardant Health sales and earnings growth
GH Growth
Neutral
  • Revenue Y/Y↑ 32.88%
  • EPS Y/Y↑ 6.74%
  • FCF Y/Y↑ 15.23%
Guardant Health gross and profit margin trends
GH Profitability
Neutral
  • Gross margin ↑ 64.50%
  • EPS margin↓ -42.40%
  • ROIC 5Y↓ -22.74%
Guardant Health net debt vs free cash flow
GH Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↑ 5.1
  • Interest coverage↓ -106.1

Guardant Health stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Diagnostics & Research stocks ↗